Benitec Biopharma Limited Selling, General and Administrative Expense of Revenue

Selling, General and Administrative Expense of Revenue of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative Expense of Revenue for the quarter ending June 30, 2022 was 0.0% (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative Expense of Revenue decreased by NaN%
  • Annual Selling, General and Administrative Expense of Revenue for 2022 was 9104.11% (a -17.51% decrease from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2021 was 11037.29% (a 6.96% increase from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2021 was 10318.64% (a 89.06% increase from previous year)
  • Twelve month Selling, General and Administrative Expense of Revenue ending June 30, 2022 was 8725.33% (a 3.21% increase compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative Expense of Revenue increased by Infinity% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
8725.33% 8453.95% 20696.55% 0.0%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative Expense of Revenue of Benitec Biopharma Limited

Most recent Selling, General and Administrative Expense of Revenueof BNTC including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative Expense of Revenue of Benitec Biopharma Limited

Benitec Biopharma Limited Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 2785.42% 9104.11%
2021 6856.0% 0.0% 71700.0% 91400.0% 11037.29%
2020 211100.0% 3340.0% -4541.67% 4596.43% 5457.84%
2019 2394.81% 2272.73% 37.82%
2018 54.75%
2017 79.38% 26.16%
2016 9.8% 98.1%
2015 85.67%
2014 120.42%
2013 94.57%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology